Scott Braunstein
CIK 1643875 · CHAIRMAN AND CEO · last filed 2026-06-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$661.3K
Companies
10
Total Filings
56
Lifetime Open-Market Net
$23.1K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ATAI | Director | — | $7.18 | — | $0 | 4 | 2026-06-08 |
| CRBU | Director | — | $1.64 | — | $0 | 5 | 2026-02-20 |
| RAPT Therapeutics, Inc. (RAPT) Delisted | Director | 4,956 | $58.01 | $287.5K | $0 | 2 | 2026-02-02 |
| MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | CHAIRMAN AND CEO | 179,536 | $0.55 | $98.7K | -$61.5K | 15 | 2025-02-11 |
| TREVENA INC (TRVN) Delisted | Director | — | $0.01 | — | $0 | 7 | 2024-06-17 |
| CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted | Director | — | $33.99 | — | $0 | 3 | 2021-06-04 |
| TARA | Director | 26,500 | $4.10 | $108.6K | $0 | 3 | 2020-06-11 |
| Alaunos Therapeutics, Inc. (ZIOP) Delisted | Director | 31,780 | $0.87 | $27.5K | $0 | 3 | 2020-01-03 |
| ESPR | Director | 5,019 | $3.18 | $16.0K | $0 | 5 | 2019-05-31 |
| PCRX | Chief Operating Officer | 20,982 | $25.58 | $536.7K | $84.6K | 7 | 2018-01-05 |
Recent Filings · Page 5 of 6
56 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-02-28 | MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-02-20 | CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-01-02 | Alaunos Therapeutics, Inc. (ZIOP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-10-01 | TREVENA INC (TRVN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-09-20 | Alaunos Therapeutics, Inc. (ZIOP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-05-25 | ESPR | Grant (A) | — | $0 | EDGAR |
| 2018-01-05 | PCRX | Grant (A) | — | $0 | EDGAR |
| 2017-06-16 | PCRX | Grant (A) | +11,000 | $0 | EDGAR |
| 2017-06-07 | PCRX | Sell (S) | −768 | -$33.3K | EDGAR |
| 2017-04-19 | ESPR | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.